Skip to content
10-Q

Quarterly Report

CATALYST PHARMACEUTICALS, INC. CPRX

0001193125-25-266854

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 122.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 127.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 127.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 125.41M sh
Shares Diluted Q3 2025 · Sep 30, 2024 124.52M sh
Capex Q3 2025 · Sep 30, 2025 $26K
Capex Q3 2025 · Sep 30, 2024 $468K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $163.78M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $168.93M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $689.89M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $517.55M
Stockholders Equity Q3 2025 · Sep 30, 2025 $920.25M
Stockholders Equity Q3 2025 · Jun 30, 2025 $856.03M
Stockholders Equity Q3 2025 · Mar 31, 2025 $794.28M
Stockholders Equity Q3 2025 · Dec 31, 2024 $727.63M
Stockholders Equity Q3 2025 · Sep 30, 2024 $660.94M
Stockholders Equity Q3 2025 · Jun 30, 2024 $608.66M
Stockholders Equity Q3 2025 · Mar 31, 2024 $561.41M
Stockholders Equity Q3 2025 · Dec 31, 2023 $387.88M
Current Liabilities Q3 2025 · Sep 30, 2025 $128.74M
Current Liabilities Q3 2025 · Dec 31, 2024 $120.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $131.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $123.78M
Current Assets Q3 2025 · Sep 30, 2025 $852.45M
Current Assets Q3 2025 · Dec 31, 2024 $623.61M
Total Assets Q3 2025 · Sep 30, 2025 $1.05B
Total Assets Q3 2025 · Dec 31, 2024 $851.41M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.42
Eps Diluted Q3 2025 · Sep 30, 2025 $1.27
Eps Diluted Q3 2025 · Sep 30, 2024 $0.35
Eps Diluted Q3 2025 · Sep 30, 2024 $0.87
Eps Basic Q3 2025 · Sep 30, 2025 $0.43
Eps Basic Q3 2025 · Sep 30, 2025 $1.32
Eps Basic Q3 2025 · Sep 30, 2024 $0.37
Eps Basic Q3 2025 · Sep 30, 2024 $0.92
Sga Expense Q3 2025 · Sep 30, 2025 $47.47M
Sga Expense Q3 2025 · Sep 30, 2025 $140.33M
Sga Expense Q3 2025 · Sep 30, 2024 $45.88M
Sga Expense Q3 2025 · Sep 30, 2024 $133.55M
Rd Expense Q3 2025 · Sep 30, 2025 $2.66M
Rd Expense Q3 2025 · Sep 30, 2025 $10.9M
Rd Expense Q3 2025 · Sep 30, 2024 $3.28M
Rd Expense Q3 2025 · Sep 30, 2024 $8.85M
Net Income Q3 2025 · Sep 30, 2025 $52.78M
Net Income Q3 2025 · Sep 30, 2025 $161.63M
Net Income Q3 2025 · Jun 30, 2025 $52.11M
Net Income Q3 2025 · Mar 31, 2025 $56.74M
Net Income Q3 2025 · Sep 30, 2024 $43.88M
Net Income Q3 2025 · Sep 30, 2024 $107.95M
Net Income Q3 2025 · Jun 30, 2024 $40.79M
Net Income Q3 2025 · Mar 31, 2024 $23.28M
Operating Income Q3 2025 · Sep 30, 2025 $66.27M
Operating Income Q3 2025 · Sep 30, 2025 $195.93M
Operating Income Q3 2025 · Sep 30, 2024 $50.91M
Operating Income Q3 2025 · Sep 30, 2024 $132.28M
Revenue Q3 2025 · Sep 30, 2025 $148.39M
Revenue Q3 2025 · Sep 30, 2025 $436.38M
Revenue Q3 2025 · Sep 30, 2024 $128.7M
Revenue Q3 2025 · Sep 30, 2024 $349.91M